Contineum Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Contineum Therapeutics has a total shareholder equity of $124.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $130.4M and $5.7M respectively. Contineum Therapeutics's EBIT is $16.1M making its interest coverage ratio -3.7. It has cash and short-term investments of $125.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -3.7x |
Cash | US$125.19m |
Equity | US$124.68m |
Total liabilities | US$5.70m |
Total assets | US$130.39m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: CTNM's short term assets ($127.7M) exceed its short term liabilities ($5.5M).
Long Term Liabilities: CTNM's short term assets ($127.7M) exceed its long term liabilities ($218.0K).
Debt to Equity History and Analysis
Debt Level: CTNM is debt free.
Reducing Debt: CTNM had no debt 5 years ago.
Debt Coverage: CTNM has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CTNM has no debt, therefore coverage of interest payments is not a concern.